Modulation of cAMP level by tedisamil in guinea pig heart

[1]  I. Imanaga,et al.  The Protective effect ofd-sotalol against hypoxia-induced myocardial uncoupling , 2005, Heart and Vessels.

[2]  M. Erez,et al.  The role of catecholamines on intercellular coupling, myocardial cell synchronization and self ventricular defibrillation , 1995, Molecular and Cellular Biochemistry.

[3]  W. Klaus,et al.  A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  L. Opie,et al.  Potential beneficial effects of potassium channel blockade by tedisamil in isolated perfused working rat heart with coronary artery ligation , 1992, Cardiovascular Drugs and Therapy.

[5]  M. Morad,et al.  The mode of action of tedisamil on voltage-dependent K+ channels , 1992, Cardiovascular Drugs and Therapy.

[6]  G. Beatch,et al.  Antiarrhythmic actions of tedisamil: Studies in rats and primates , 1992, Cardiovascular Drugs and Therapy.

[7]  N. Tribulova,et al.  Hypokalemia-induced ultrastructural, histochemical and connexin-43 alterations resulting in atrial and ventricular fibrillations. , 1999, General physiology and biophysics.

[8]  W. D. De Mello,et al.  Effect of tedisamil on cell communication, impulse propagation, and excitability of the failing heart. , 1999, European journal of pharmacology.

[9]  N. Tribulova,et al.  Is the Antiarrhythmic Effects of PA Related to Wavelength , 1999 .

[10]  N. Tribulova,et al.  The protective effect of class III antiarrhythmic agents against calcium overload in cultured myocytes. , 1997, Life sciences.

[11]  E. Piedras-Rentería,et al.  Effects of relaxin on rat atrial myocytes. I. Inhibition of I(to) via PKA-dependent phosphorylation. , 1997, The American journal of physiology.

[12]  J E Saffitz,et al.  Functional and structural assessment of intercellular communication. Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes. , 1996, Circulation research.

[13]  L. Virág,et al.  The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibers. , 1996, Cardiovascular research.

[14]  Y. Watanabe,et al.  Is cyclic AMP involved in the defibrillating effect of sotalol? , 1995, Life sciences.

[15]  M. Curtis,et al.  Brief, intermediate and prolonged ischemia in the isolated crystalloid perfused rat heart: relationship between susceptibility to arrhythmias and degree of ultrastructural injury. , 1995, Journal of molecular and cellular cardiology.

[16]  K. Weber.  Chaos in the Hall of Mirrors. , 1995, Cardiovascular research.

[17]  A. Camm,et al.  Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction: rationale, design, and methods (the SWORD trial). , 1995, The American journal of cardiology.

[18]  J. Lynch,et al.  Cardiac electrophysiologic and antiarrhythmic actions of tedisamil. , 1995, The Journal of pharmacology and experimental therapeutics.

[19]  M. Spach,et al.  Altering the topology of gap junctions a major therapeutic target for atrial fibrillation. , 1995, Cardiovascular research.

[20]  N S Peters,et al.  Cardiac arrhythmogenesis and the gap junction. , 1995, Journal of molecular and cellular cardiology.

[21]  M. Schlepper,et al.  Tedisamil (KC 8857) is a new specific bradycardic drug: does it also influence myocardial contractility? Analysis by the conductance (volume) technique in coronary artery disease. , 1993, American heart journal.

[22]  K. Arakawa,et al.  A fast fourier transform analysis of coronary reperfusion‐induced ventricular fibrillation and the modification by dibutyryl cyclic amp in a cat model , 1992, Clinical cardiology.

[23]  B. MacLeod,et al.  Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker , 1991, British journal of pharmacology.

[24]  E. Lakatta,et al.  Role of calcium and the calcium channel in the initiation and maintenance of ventricular fibrillation. , 1990, Circulation research.

[25]  D C Spray,et al.  Inotropic agents modulate gap junctional conductance between cardiac myocytes. , 1988, The American journal of physiology.

[26]  D. B. Evans.  Modulation of cAMP: Mechanism for Positive Inotropic Action , 1986, Journal of cardiovascular pharmacology.

[27]  D. Coltart,et al.  The genesis of arrhythmias during myocardial ischemia. Dissociation between changes in cyclic adenosine monophosphate and electrical instability in the rat. , 1985, Circulation research.

[28]  E. Krause,et al.  Myocardial cyclic nucleotide levels following coronary artery ligation. , 1978, Advances in cardiology.

[29]  W. Parmley,et al.  Comparative effects of sotalol and propranolol on contractility of papillary muscles and adenyl cyclase activity of myocardial extracts of cat. , 1972, The Journal of clinical pharmacology and new drugs.